"As a physician-researcher, I’ve been deep-divin
Post# of 154115
(Total Views: 548)
Posted On: 06/12/2025 6:14:19 AM
Re: USS JOHNSTON #154090
"As a physician-researcher, I’ve been deep-diving into Leronlimab’s dual mechanism of action — not only as an anti-metastatic agent, but also as a potential immunotherapy primer."
Are there any current drugs with this "dual mechanism"; that is, it not only combats Tnbc, but identifies patients who may benefit from immunotherapy? Am I understanding this correctly?
Are there any current drugs with this "dual mechanism"; that is, it not only combats Tnbc, but identifies patients who may benefit from immunotherapy? Am I understanding this correctly?
(3)
(0)